2023+中国专家共识：高危老年慢性冠脉综合征患者的抗栓治疗（英文）.pdfVIP

Received: 2 November 2022   Accepted: 2 December 2022 | DOI: 10.1002/agm2.12234 G U I D E L I N E Chinese expert consensus on antithrombotic management of high- risk elderly patients with chronic coronary syndrome 1 2 Cuntai Zhang   | Xiaoming Wang   | Cardiovascular Group, Geriatrics Branch of Chinese Medical Association 1Department of Geriatrics, Tongji Hospital, Tongji Medical College, Abstract Huazhong University of Science The prevalence and mortality of coronary artery disease (CAD) in China are still at an Technology, Wuhan, China 2 increasing stage. CAD can be classified as acute coronary syndrome (ACS) or chronic Department of Geriatrics, Xijing Hospital, Air Force Medical University, Xian, China coronary syndrome (CCS). CCS is the main manifestation type of elderly patients with Correspondence CAD, with a large number of patients, long course of disease, and poor prognosis, Cuntai Zhang, Department of Geriatrics, leading to decreased quality of life and heavy disease burden and economic burden. Tongji Hospital, Tongji Medical College, Especially in patients with high-risk CCS, the case fatality rate and total mortality are Huazhong University of Science Technology, Wuhan 430030, China. high. In order to better standardize the antithrombotic treatment of elderly patients Email: ctzhang0425@163.com with high- isk CCS, the Geriatrics Branch of the Chinese Medical Association organ- r Xiaoming Wang, Department of Geriatrics, izes domestic experts to develop this consensus